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G.L. Sayer1* and P.D.C. Smith2Departments of 1Vascular Surgery, King’s College Hospital, and 2Surgery, University College Hospital,
London, UKObjectives. To characterise the inflammatory cell infiltrate in varicose vein wall, and its relationship to the valve complex.
Design. A comparative study of the distribution of inflammatory cells in normal and varicose vein.
Materials. Specimens of proximal human long saphenous vein were obtained from patients with duplex Doppler confirmed
long saphenous vein reflux (nZ14). Control vein was obtained from patients undergoing coronary artery bypass without
clinical evidence of venous insufficiency (nZ6). Longitudinal 7 mm frozen sections of vein, displaying valve, were prepared.
Methods. Using immunohistochemistry, T-lymphocytes (CD3), macrophage/monocytes (CD68), neutrophils (CD15s) and
mast cells (anti-mast cell tryptase) were identified. The number of cells per unit length vein were counted using light
microscopy.
Results. There were significantly more mast cells and macrophage/monocytes in varicose vein as compared to control. There
was a non-significant trend towards more T-lymphocytes in varicose vein. Few neutrophils were present in varicose or
normal vein. The distribution of inflammatory cells with respect to the valve was not found to be significant.
Conclusions. Varicose veins display a greater inflammatory cell infiltrate than normal vein. The key role of
macrophage/monocytes and mast cells in tissue damage and remodelling should stimulate further research into whether
they play a significant role in the development of chronic venous insufficiency.Keywords: Varicose vein; Inflammatory cells; Immunohistochemistry; Pathophysiology.Introduction
Varicose veins are one of the commonest reasons for
surgical intervention in the Western world and yet
very little is known about their pathophysiology. The
prevalence of varicose veins in the western population
over the age of 15 years has been estimated at between
10 and 15% for men and 20 and 25% for women.1
It is only with the advent of duplex ultrasonogra-
phy that we have been able to fully appreciate the role
of valvular incompetence in the development of
varicose veins. It has been shown that the number of
incompetent valves correlates with the development
of other features of chronic venous disease such as
lipodermatosclerosis and ulceration.2–5
Failure of the valves in perforating veins impairs
the normal pathways of venous return from the lower
limb and is amongst the earliest features in the
development of chronic venous disease. The aetiologying author. G. L. Sayer, Specialist Registrar, Depart-
lar Surgery, King’s College Hospital, London SE5 9RS,
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suggested that a primary pathological process affects
the valves rendering them incompetent. Histological
studies have demonstrated a disruption of the
organisation of the extracellular matrix and smooth
muscle architecture in the vessel wall of varicose
veins6–8 and the marked thinning of the vessel wall at
the site of the varices.7
Further research into the aetiology of varicose veins
looked at the differences in the biochemistry of
varicose veins in comparison to normal vein. It has
been demonstrated that there is a reduction in the
elastin content9–12 and an increase in collagen con-
tent.9,10,13,14 Other research has shown an increase in
fibrinolytic activity in varicose veins,15 increased
prostaglandin production,16 increased endothelin-1
production17 and a reduction in expression of the
endothelin B receptor subtype.18
The role of inflammatory cells in the development
of the histological and biochemical changes observed
has not been established. It is known that in venous
thrombosis and thrombophlebitis there is an inflam-
matory response in the vessel wall and it is suggestedEur J Vasc Endovasc Surg 28, 479–483 (2004)
doi:10.1016/j.ejvs.2004.07.023, available online at http://www.sciencedirect.com onved.
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increase in mast cells19 and of macrophage-mono-
cytes20 has been previously demonstrated in varicose
veins. It is also suggested that there is a concentration
of the inflammatory cells in the valve sinus and vessel
wall proximal to the valve20 and that this might result
in subsequent valve damage.
We have characterised the inflammatory cell infil-
trate in varicose veins and examined their distribution
with respect to the valve, and compared the histologi-
cal changes evident in the varicose vein in comparison
to normal samples of vein.Methods
Ethical approval was obtained from the Joint
UCL/UCLH Committees on the Ethics of Human
Research Ethics Committee, University College
London. Patients referred with venous disease were
pre-operatively assessed by an experienced vascular
surgeon and underwent venous duplex Doppler
assessment. Patients with evidence of deep venous
incompetence on scanning or history of previous deep
vein thrombosis were excluded from the study.
Symptomatic patients with superficial varicose veins
were recruited to the study following assessment by
the surgeon. Specimens were obtained from patients
with duplex Doppler proven reflux in the saphenofe-
moral junction and the proximal long saphenous,
which was confirmed prior to surgery. Control speci-
mens were obtained from patients who were to
undergo long saphenous vein harvesting for coronary
artery bypass grafting (CABG). These patients were
assessed pre-operatively and any patient with clini-
cally apparent varicose veins features of chronic
venous insufficiency or a history suggestive of,Table 1. (a) Clinical details of patients undergoing varicose vein surg
Specimen Sex Age Duration o
(years)
1 M 63 O20
2 F 42 3
3 F 30 9
4 F 51 10
5 M 32 4
6 F 32 5
7 F 36 2
8 F 56 O20
9 F 32 10
10 F 58 10
11 M 29 4
12 F 47 6
13 M 47 10
14 M 70 10
Five males, nine females; mean ageZ44.6 years; medianZ9 years; PZ
* Hawaii classification of lower extremity venous disease.
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Informed consent was obtained from all patients
involved in the study.
Tissue specimens were obtained from 14 patients
undergoing surgery for varicose veins, and control
specimens from six patients (Table 1(a) and (b)). The
specimens were taken from the proximal long saphe-
nous vein at the level of the saphenofemoral junction
by excision of the proximal 5–10 cm of vein prior to
vein stripping in patients undergoing varicose vein
surgery and at the time of vein harvest in patients
undergoing CABG.
The specimens obtained were examined macro-
scopically to identify the pre-terminal valve complex
of the long saphenous vein and were then divided
longitudinally to provide two specimens one of which
was frozen in liquid nitrogen within an embedding
media, O.C.T. compound (Tissue-Tek, Miles Inc. USA).
The second specimen was fixed in 4% paraformalde-
hyde and embedded in paraffin as previously
described. Slides were subsequently prepared from
the frozen section (7 mm) and wax specimens (5 mm)
for histological analysis.
The morphology of the valve complex and vessel
wall was examined in each specimen using sections
prepared with haematoxylin and eosin and Masson’s
Trichrome staining methods. The detection and
quantification of inflammatory cells was undertaken
using frozen section immunohistochemistry and
stained using the avidin–biotin immunoperoxidase
complex technique. T-cells were identified with anti-
CD3 antibodies; macrophage-monocytes with anti-
CD68 antibodies, neutrophils with anti-CD15s
antibodies and mast cells were identified using anti-
mast cell tryptase antibodies (Table 2).
Serial sections were fixed in ice-cold acetone for
20 min before being washed in neutral PBS buffer forery
f symptoms Aetiology Clinical grade* of
venous disease
P C3
P C2
P C2
P C2
P C3
P C2
P C2
P C4
P C2
P C3
P C2
P C2
P C5
P C6
primary aetiology.
Table 1. (b) Clinical details of control patients
Specimen Sex Age Venous symptoms
C1 M 50 Nil
C2 M 57 Nil
C3 M 72 Nil
C4 M 60 Nil
C5 M 68 Nil
C6 M 65 Nil
Mean age 62.0 years.
Fig. 1. Localised collections of T-lymphocytes (arrow)
adjacent to the valve agger (a). (Longitudinal section of
vein, !5 magnification, monoclonal anti CD3 antibody).
Inflammatory Cells in Varicose Vein 48110 min. Sections were then treated with 0.3% hydrogen
peroxide to quench endogenous peroxidases before a
repeat wash with neutral PBS buffer. Sections were
then treated with 3% horse serum for 30 min before
incubation with the primary antibodies as listed in
Table 1(a) and (b) for 60 min. Sections were washed in
PBS neutral buffer again before application of a
biotinylated anti-mouse IgG raised in horse for
30 min followed by a further wash in PBS. Finally
the sections were incubated with Vectastain reagent (a
macromolecular complex of avidin and biotinylated
horseradish peroxidase) for 30 min, before being
imaged with 0.1% diaminobenzidine tetrahydrochlor-
ide for 3 min. Samples of inflamed human skin were
used as positive controls in the absence of tissue
specific for each inflammatory marker. Negative
controls were undertaken by omitting the primary
antibody and using a further sample of the appro-
priate serum for the primary antibody in its place.
Serial sections of vein were stained for the four
inflammatory cell markers. Cells were then counted
for each 500 mm of vessel wall using an index-squared
graticule. A single count was taken at the level of the
valve agger and five consecutive counts were then
taken from above and below the valve agger. In total 11
counts were taken from each specimen representing a
total length of 5.5 cm of vessel wall.
Statistical analysis was undertaken assuming the
data was non-normally distributed. The median
interquartile range was calculated and the confidence
intervals (95%) were calculated for the difference
between the two medians using Confidence Interval
Analysis (Version 1.1, q Professor Martin J. Gardner
and the British Medical Journal) and a p-value calcu-
lated using Mann–Whitney U-test for non-parametric
data.Table 2. Monoclonal antibodies used to identify inflammatory cells
Inflammatory cells CD marker Monoclonal antib
T-cells CD3 Mouse anti-huma
Macrophage-monocytes CD 68 Mouse anti-huma
Neutrophils CD 15 s Mouse anti-huma
Mast cells Mouse anti-humaResults
Histological comparison of the control and varicose
specimens demonstrated characteristic features associ-
ated with varicose veins that were not found in the
control samples. These included areas of marked
thinning of the vessel wall associated with disruption
of the tissue architecture, thickening of the intima and
disorganisation of the media. It was also noted that
there was a much greater degree of thinning of the
valve wall above the valve agger when compared to
the normal vein specimens which may be important in
disrupting the function of the valve complex.
There was found to be a significant increase of both
mast cells and macrophage-monocytes in the varicose
vein as compared to the control specimens (Table 3).
There was found to be a non-significant increase in the
number of T-lymphocytes in varicose vein when
compared with controls. The distribution of neutro-
phils was scanty in both normal and varicose vein with
no significant difference.
No significant variation in the distribution of any ofin vein specimens
ody Epitope Source/dilution
n IgG Surface protein Serotec 1:20
n IgG Intracytoplasmic lysosomal Serotec 1:200
n IgM Sialyl Lewis X Serotec 1:100
n IgG Mast cell tryptase Serotec 1:200
Eur J Vasc Endovasc Surg Vol 28, November 2004
Fig. 2. Macrophage-monocytes (arrow) in varicose vein and
the valve complex (v). (Longitudinal section, !10 magnifi-
cation, anti Ki-M6 antibody).
G. L. Sayer and P. D. C. Smith482the inflammatory cells either above or below the valve
was detected. The distribution of the inflammatory
cells within the vessel wall was varied. T-lymphocytesFig. 3. Mast cell distribution (arrow) around the valve (v) in
varicose vein. (Longitudinal section,!5 magnification, anti-
human mast cell tryptase monoclonal antibody).
Eur J Vasc Endovasc Surg Vol 28, November 2004were often found in localised collections near the valve
agger at the level of transition in the vein from the
media to the adventitia (Fig. 1). This was observed in
both varicose and normal vein. Macrophage-mono-
cytes (Fig. 2) and mast cells (Fig. 3) were found widely
distributed throughout the vessel wall.Discussion
This study has demonstrated evidence of an increased
inflammatory cell infiltrate of both mast cells and
macrophage-monocytes in histologically characterised
varicose vein when compared to normal control
samples. The characteristic histological changes of
varicose veins, including thinning of the vessel wall at
the site of a varix; disruption of the smooth muscle
architecture and deposition of collagenous connective
tissue in the vessel wall7 were clearly identified in the
varicose and not in the control specimens. The
increasing age and predominance of the male sex in
the control group may have unanticipated effects on
the results.
These histological changes occur as a consequence
of an unknown pathological process. The tissue
remodelling observed in varicose veins must require
a cell-mediated process and the presence of increased
mast cells and macrophage-monocytes within varicose
vein suggests that they may have an important role in
this pathological process.
Macrophage-monocytes can release growth factors,
proinflammatory cytokines and matrix metallopro-
teases, and as such play a key role in tissue remodelling.
In addition, it is thought that macrophage-monocytes
can further enhance cell adhesion molecule expression
by vascular endothelium21 and can induce changes in
the smooth muscle phenotype.22 The localisation of
macrophage-monocytes in the region of the valves of
varicose vein has been previously observed20 and it is
suggested that they are more commonly observed
adherent to the valve and in the vein wall above the
valve complex. These findings were not replicated in
this study.
Mast cells also play an important role in the genesis
of an inflammatory response through the releases of
vasoactive substances23 and have been shown to be
potent regulators of endothelial cell adhesion mol-
ecule expression.24
The mechanism by which valvular incompetence
occurs remains obscure. This study has demonstrated
that the histological features of valvular incompetence
are clearly associated with the presence of an
inflammatory cell infiltrate. Further research is needed
to identify what stimulates localisation of
Table 3. Median cell counts per 5.5 mm vein wall (inter-quartile range)
Macrophages and
monocytes
Mast cells T-lymphocytes Neutrophils
Control vein 36.5 (19.5–45.3) 9 (8–10) 42 (29–42) 2
Varicose vein 133 (84.8–196.3) 24 (17–33.3) 49 (30–67) 1
Median difference (95%
confidence Interval)
93 (43–166) PZ0.001 13 (2.0–27) PZ0.017 7 (K18–40) PZ0.916 1 (0–2) PZ0.562
Inflammatory Cells in Varicose Vein 483inflammatory cells within the vessel wall and how
they are involved in the histological changes observed.References
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